Why the study?
Renal complications from persistent uncontrolled hypertension, including renovascular hypertension and hypertensive emergency-related nephropathy, involve hyperreninemia and contribute to nephropathy progression.
Highlights modern histopathological findings of hypertensive nephropathy, moving away from classic fibrinoid necrosis to arteriolar endothelial proliferation, and cautions on potential long-term morphological changes from ACEI/ARB therapy.
Renal complications resulting from persistent, uncontrolled hypertension include renovascular hypertension (RVH) and hypertensive emergency (crisis)-related nephropathy (HEN), both of which are characterized by hyperreninemia and are involved in the progression of nephropathy. In RVH, renal artery stenosis leads to increased renin secretion from the affected kidney, which induces focal segmental glomerulosclerosis (FSGS) lesions in the contralateral kidney, resulting in proteinuria. In HEN, severe hypertension (>200/120 mmHg) induces endothelial cell proliferation in renal arterioles, resulting in edematous thickening of the intima and narrowing of the lumen. This process increases renin secretion from the juxtaglomerular apparatus (JGA), further worsening hypertension and resulting in glomerular collapse and rapidly progressive renal impairment. Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) suppress aldosterone activity and promote renin activity, respectively. Prolonged administration has been suggested to lead to JGA hyperplasia and smooth muscle cell proliferation in the renal arterioles.
No takes yet. Share an insight, caveat, or question.
Ubara et al. (2026) conducted a review in Renovascular hypertension and hypertensive emergency-related nephropathy. Persistent hypertension and ACEI/ARB use was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: